1. Continuous Temperature Telemonitoring of Patients with COVID-19 and Other Infectious Diseases Treated in Hospital-at-Home: Viture ® System Validation.
- Author
-
Sesma-Sánchez L, Ruiz-Castellano M, Romero-Roldán A, Álvarez-García L, Morrás-Gómez M, Tabar-Liberal I, Pulido-Fontes M, and Salmón-García B
- Subjects
- Humans, Male, Female, Middle Aged, Aged, Telemedicine, Adult, Thermometers, Monitoring, Physiologic methods, Monitoring, Physiologic instrumentation, Aged, 80 and over, COVID-19 diagnosis, Body Temperature, Fever diagnosis, Fever physiopathology, SARS-CoV-2 isolation & purification
- Abstract
Body temperature must be monitored in patients receiving Hospital-at-Home (HaH) care for COVID-19 and other infectious diseases. Continuous temperature telemonitoring (CTT) detects fever and patient deterioration early, facilitating decision-making. We performed a validation clinical study assessing the safety, comfort, and impact on healthcare practice of Viture
® , a CTT system, compared with a standard digital axillary thermometer in 208 patients with COVID-19 and other infectious diseases treated in HaH at the Navarra University Hospital (HUN). Overall, 3258 pairs of measurements showed a clinical bias of -0.02 °C with limits of agreement of -0.96/+0.92 °C, a 95% acceptance rate, and a mean absolute deviation of 0.36 (SD 0.30) °C. Viture® detected 3 times more febrile episodes and revealed fever in 50% more patients compared with spot measurements. Febrile episodes were detected 7.23 h (mean) earlier and modified the diagnostic and/or therapeutic approach in 43.2% of patients. Viture® was validated for use in a clinical setting and was more effective in detecting febrile episodes than conventional methods.- Published
- 2024
- Full Text
- View/download PDF